Rozman C, Marín P, Nomdedeu B, Montserrat E
Postgraduate School of Haematology Farreras Valenti, Hospital Clinic i Provincial, Barcelona, Spain.
Lancet. 1987 Oct 24;2(8565):955-7. doi: 10.1016/s0140-6736(87)91432-2.
To study the validity of currently accepted international criteria for severe aplastic anaemia, 213 consecutive cases of bone marrow aplasia from a single institution were analysed. The distribution percentiles of peripheral blood values and multivariate analysis showed that the current reticulocyte count limit of 1% (corrected for haematocrit) is inadequate an an indicator of severe disease and should be substantially lowered. Since the choice of treatment in aplastic anaemia may depend on the prognosis current criteria for severe aplastic anaemia should be modified.
为研究目前公认的重型再生障碍性贫血国际标准的有效性,对来自单一机构的213例连续性骨髓再生障碍病例进行了分析。外周血值的分布百分位数和多变量分析表明,目前网织红细胞计数下限1%(根据血细胞比容校正)作为严重疾病的指标并不充分,应大幅降低。由于再生障碍性贫血的治疗选择可能取决于预后,因此应修改目前的重型再生障碍性贫血标准。